Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
16,197,337
-
Share change
-
+4,143,564
-
Total reported value
-
$50,860,481
-
Price per share
-
$3.14
-
Number of holders
-
69
-
Value change
-
+$13,582,955
-
Number of buys
-
41
-
Number of sells
-
23
Institutional Holders of CHECKPOINT THERAPEUTICS INC - COM (CKPT) as of Q1 2021
As of 31 Mar 2021,
CHECKPOINT THERAPEUTICS INC - COM (CKPT) was held by
69 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,197,337 shares.
The largest 10 holders included
BlackRock Inc., Opaleye Management Inc., VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, Spotlight Asset Group, Inc., MORGAN JESS S & CO INC, NORTHERN TRUST CORP, DEUTSCHE BANK AG\, and MORGAN STANLEY.
This page lists
69
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.